JAG1 and myeloid sarcoma: As MS is considered a demyelinating disease (Hauser and Oksenberg, 2006; Compston and Coles, 2008; Steinman, 2014; Ransohoff et al., 2015), we first sought to determine whether the AGS+ rhAbs recognized components of the corpus callosum, which is enriched for myelin tracts.